Attached files
| file | filename |
|---|---|
| EX-32.3 - EXHIBIT 32.3 - PLURISTEM THERAPEUTICS INC | exhibit_32-3.htm |
| EX-32.2 - EXHIBIT 32.2 - PLURISTEM THERAPEUTICS INC | exhibit_32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - PLURISTEM THERAPEUTICS INC | exhibit_32-1.htm |
| EX-31.3 - EXHIBIT 31.3 - PLURISTEM THERAPEUTICS INC | exhibit_31-3.htm |
| EX-31.2 - EXHIBIT 31.2 - PLURISTEM THERAPEUTICS INC | exhibit_31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - PLURISTEM THERAPEUTICS INC | exhibit_31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - PLURISTEM THERAPEUTICS INC | exhibit_23-1.htm |
| EX-10.41 - EXHIBIT 10.41 - PLURISTEM THERAPEUTICS INC | exhibit_10-41.htm |
| 10-K - 10-K - PLURISTEM THERAPEUTICS INC | zk1720512.htm |
Exhibit 10.40
August 15, 2017
To:
Sosei Corporate Venture Capital Ltd.
Attn: Mr. Peter Bains
Re: Extension of Term Sheet Period
Reference is hereby made to a certain Term Sheet dated December 19, 2016, by and between Pluristem Ltd. and Sosei Corporate Venture Capital Ltd. (the “Term Sheet”).
Pursuant to the “Timing and Expenses” clause in the Term Sheet, the parties hereby extend the term sheet period by additional 180 days starting from July 1st, 2017 and ending on December 31st, 2017.
|
|
Very truly yours,
Pluristem Ltd.
By: /s/ Zami Aberman
Name: Zami Aberman
Title: Chairman and Co-CEO
|
The abovementioned decision is agreed and accepted by:
Sosei Corporate Venture Capital Ltd.
By: /s/ Peter Bains
Name: Peter Bains
Title: CEO
